If you’ve come this far and are interested in participating in research studies conducted in clinical research institutes in Michigan, Georgia, Nebraska, North Carolina, Illinois, or Texas, contact us or call us at: +1 (248) 721-9539.

However, it is important you talk to your primary care physician before participating in any clinical trial. Feel free to ask as many questions as you want about what participating in a research study entails before volunteering.

Clinical trials help us progress against diseases by testing the safety and efficacy of new medicines and therapies. All medicines and vaccines that become available today for use in people are first tested in studies involving hundreds to thousands of volunteers. Volunteering to take part in clinical drug research is one of the most effective ways YOU could contribute to the understanding of diseases that afflict people and the development of new drugs.

Clinical research coordinators (CRC) are responsible for supervising all aspects of the clinical trials in a clinical research center. They are responsible for recruiting and screening patients for clinical trials. Coordinators are also responsible for the safety of all the materials that may be used during the trial, and they must ensure that all documents remain up to date with patient and research information.

As a participant in a clinical trial, your information, test results, and screening will all be handled by a CRC. They will guide you through the informed consent process and will help you through questions or issues you may have with your treatment.

To test the safety and efficacy of a treatment, the series of clinical trials unfold in 4 phases.

• As a volunteer in a Phase I clinical trial, you will assist researchers in learning about the safety of a study drug. You may be subjected to periodic clinical checkups and lab work, and you will be required to report any problems or adverse effects.
• In Phase II clinical trial, you will be assisting researchers in gaining a better understanding of how effectively the study drug may perform for the disease being investigated, as well as the potential adverse effects.
• In Phase III clinical study, you will be a member of a bigger group of people (approx. several hundred to several thousand participants) with the same medical condition being examined. Your involvement assists us in determining if the study medication is safe and effective for persons suffering from that disease.
• In Phase IV, the drug is usually approved by FDA, however, you can continue to take part in long-term clinical trials to better understand the effects of the approved treatment over time. This may take a year or more after the drug has been approved.

Every clinical trial has a possible risk. Before you participate in the clinical trial, the risks and possible benefits of your participation and taking the study drug will be explained to you in detail during the Informed Consent process.

As per the requirement of every clinical research organization, we must follow guidelines and regulatory requirements to help protect the rights, safety, and well-being of all participants. These include Good Clinical Practice (GCP). GCP is an international ethical and scientific quality standard for clinical trial design and execution.

Many entities are involved in your and other volunteers’ participation. This includes the U.S. Food & Drug Administration (FDA), institutional review boards (IRB), and data safety and monitoring boards.

Yes, volunteers are free to stop being in a research study at any time and for any reason. Participation in a clinical trial is completely voluntary.

An Investigational Drug or an Investigational Product is also known as an experimental drug. It is studied in a research trial to see if your medical condition or disease improves. Throughout the clinical research study, researchers may be able to evaluate if the investigational drug is safe or effective, how it might be used to combat the disease, and, the potential risks and benefits of taking the drug. An investigational drug may be approved by the FDA for use in one disease or condition but still be considered investigational in other diseases or conditions.